Cragg MS - Search Results

1

Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.

Stopforth RJ, Oldham RJ, Tutt AL, Duriez P, Chan HTC, Binkowski BF, Zimprich C, Li D, Hargreaves PG, Cong M, Reddy V, Leandro MJ, Cambridge G, Lux A, Nimmerjahn F, Cragg MS. Stopforth RJ, et al. Among authors: cragg ms. J Immunol. 2018 Mar 1;200(5):1937-1950. doi: 10.4049/jimmunol.1700832. Epub 2018 Jan 19. J Immunol. 2018. PMID: 29351998 Free PMC article.

2

The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease.

Zhang L, French RR, Chan HT, O'Keefe TL, Cragg MS, Power MJ, Glennie MJ. Zhang L, et al. Among authors: cragg ms. Ther Immunol. 1995 Aug;2(4):191-202. Ther Immunol. 1995. PMID: 9358611

3

The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.

Cragg MS, Chan HT, Fox MD, Tutt A, Smith A, Oscier DG, Hamblin TJ, Glennie MJ. Cragg MS, et al. Blood. 2002 Nov 1;100(9):3068-76. doi: 10.1182/blood.V100.9.3068. Blood. 2002. PMID: 12384401 Free article.

4

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts.

Cragg MS, Morgan SM, Chan HT, Morgan BP, Filatov AV, Johnson PW, French RR, Glennie MJ. Cragg MS, et al. Blood. 2003 Feb 1;101(3):1045-52. doi: 10.1182/blood-2002-06-1761. Epub 2002 Sep 19. Blood. 2003. PMID: 12393541 Free article.

5

CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts.

Chan HT, Hughes D, French RR, Tutt AL, Walshe CA, Teeling JL, Glennie MJ, Cragg MS. Chan HT, et al. Among authors: cragg ms. Cancer Res. 2003 Sep 1;63(17):5480-9. Cancer Res. 2003. PMID: 14500384

6

A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells.

Cragg MS, Bayne MB, Tutt AL, French RR, Beers S, Glennie MJ, Illidge TM. Cragg MS, et al. Blood. 2004 Oct 15;104(8):2540-2. doi: 10.1182/blood-2004-05-1733. Epub 2004 Jun 22. Blood. 2004. PMID: 15213098 Free article.

7

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

Beers SA, French RR, Chan HT, Lim SH, Jarrett TC, Vidal RM, Wijayaweera SS, Dixon SV, Kim H, Cox KL, Kerr JP, Johnston DA, Johnson PW, Verbeek JS, Glennie MJ, Cragg MS. Beers SA, et al. Among authors: cragg ms. Blood. 2010 Jun 24;115(25):5191-201. doi: 10.1182/blood-2010-01-263533. Epub 2010 Mar 11. Blood. 2010. PMID: 20223920 Free article.

8

Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects.

Hampson G, Ward TH, Cummings J, Bayne M, Tutt AL, Cragg MS, Dive C, Illidge TM. Hampson G, et al. Among authors: cragg ms. J Immunol Methods. 2010 Aug 31;360(1-2):30-8. doi: 10.1016/j.jim.2010.05.009. Epub 2010 Jun 11. J Immunol Methods. 2010. PMID: 20547164

9

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.

Alduaij W, Ivanov A, Honeychurch J, Cheadle EJ, Potluri S, Lim SH, Shimada K, Chan CH, Tutt A, Beers SA, Glennie MJ, Cragg MS, Illidge TM. Alduaij W, et al. Among authors: cragg ms. Blood. 2011 Apr 28;117(17):4519-29. doi: 10.1182/blood-2010-07-296913. Epub 2011 Mar 4. Blood. 2011. PMID: 21378274 Free PMC article.

10

Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration.

Lunnon K, Teeling JL, Tutt AL, Cragg MS, Glennie MJ, Perry VH. Lunnon K, et al. Among authors: cragg ms. J Immunol. 2011 Jun 15;186(12):7215-24. doi: 10.4049/jimmunol.0903833. Epub 2011 May 13. J Immunol. 2011. PMID: 21572034 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page